13 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 52.1% per year over the past 5 years.
Operating margin has contracted, at -9867.9% in the latest year.
Financial health
Total debt has grown faster than revenue (66.7% vs -52.1% per year).
Operating income covered interest expense -10.4× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$431609
-$42M
76.8%
-9867.9%
—
—
$7M
2024
$136643
$9M
4.4%
-10758.7%
-$14M
$3M
—
2023
$1M
-$18M
3.6%
-322.4%
—
—
$361
2022
$10M
-$3M
53.8%
-28.4%
—
—
$1M
2021
$10M
-$5M
48.0%
-53.5%
-$3M
—
$3M
2020
$17M
-$3M
33.3%
-14.6%
-$2M
—
$6M
2019
$7M
-$284428
65.5%
1.7%
—
$225000
$3M
2018
$4M
$9038
88.3%
-2.3%
—
$522052
$869557
2017
—
$288983
—
—
—
$666516
$183914
2016
—
-$3M
—
—
—
—
$14679
2015
—
-$1M
—
—
—
—
$78708
2014
—
-$2M
—
—
—
—
$695817
2013
—
-$2M
—
—
-$855568
—
$84317
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$56325
-$3M
95.6%
-6230.8%
—
—
—
Dec '25
-$168699
-$28M
144.5%
17487.0%
—
—
$7M
Sep '25
$590050
-$4M
97.4%
-739.1%
—
$2M
—
Jun '25
$0
-$7M
—
—
—
$4M
—
Mar '25
$10258
-$3M
6.6%
-34814.9%
—
$3M
—
Dec '24
$53083
-$7M
5.3%
-7939.6%
-$3M
$3M
—
Sep '24
$64861
-$3M
6.0%
-5392.7%
—
—
—
Jun '24
$18699
-$2M
-3.8%
-7998.8%
—
—
—
Mar '24
—
$21M
—
—
—
—
$3M
Dec '23
$128662
-$12M
-88.6%
-1751.6%
—
—
$361
Sep '23
$392286
-$4M
10.1%
-194.2%
—
—
$34031
Jun '23
$366526
-$2M
18.3%
-163.6%
—
—
$745561
Mar '23
$493316
-$677953
14.8%
-163.4%
—
—
$1M
Dec '22
$2M
-$925186
67.2%
-47.1%
—
—
$1M
Sep '22
$2M
-$503003
66.8%
-10.6%
—
—
$321715
Jun '22
$3M
-$1M
35.7%
-33.6%
—
—
$962227
Mar '22
$3M
-$965836
41.2%
-29.9%
—
—
$2M
Dec '21
$2M
-$784340
51.9%
-32.8%
—
—
$3M
Sep '21
$3M
-$1M
50.2%
-50.8%
—
—
$4M
Jun '21
$2M
-$3M
44.3%
-135.4%
—
—
$5M
Valuation over time
How the market has priced SCNX against its own fundamentals since 2024-09 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 27.2× (Dec '24) to 2.7× (Nov '25).
The price-to-sales ratio has fallen from 222.5× (Sep '24) to 34.5× (Jun '26).
The dividend yield has risen from 6.0% (Dec '24) to 61.4% (Nov '25).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is SCNX growing its revenue and profit?
Over the past 5 years, Scienture Holdings, Inc.'s revenue has declined 52.1% per year. These are computed facts, not advice.
How much debt does SCNX have?
As of FY2025, Scienture Holdings, Inc. reported — of total debt against $7M of cash; operating income covered interest expense -10.4×.
What is SCNX's profit margin?
In FY2025, gross margin was 76.8%, operating margin -9867.9%, and net margin -9618.0%.
What is SCNX's P/E ratio?
As of Jun '26, Scienture Holdings, Inc. traded at a price-to-earnings ratio of about 2.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.